Tissue levels of metaraminol and its metabolite, alpha-methylnorepinephrine, in control and 6-hydroxydopamine-pretreated guinea pigs.
D000818:Animals; D006168:Guinea Pigs; D006207:Half-Life; D006321:Heart / Q000187:drug effects; D006892:Hydroxydopamines / Q000494:pharmacology*; D007700:Kinetics; D008099:Liver / Q000187:drug effects / Q000378:metabolism; D008297:Male; D008680:Metaraminol / Q000378:metabolism*; D009206:Myocardium / Q000378:metabolism; D008771:Nordefrin / Q000378:metabolism*; D009638:Norepinephrine / Q000031:analogs & derivatives* / Q000378:metabolism; D016627:Oxidopamine
D006892:Hydroxydopamines; D008680:Metaraminol; D016627:Oxidopamine; D008771:Nordefrin; D009638:Norepinephrine